NPI: 1851936983 · FRANKLIN, VA 23851 · General Acute Care Hospital · NPI assigned 11/13/2019
Authorized official RALSTON, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | RALSTON, KIMBERLY (SYSTEM DIRECTOR) |
| NPI Enumeration Date | 11/13/2019 |
Other providers sharing the same authorized official: RALSTON, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 34,367 | $1.34M |
| 2021 | 43,508 | $1.55M |
| 2022 | 44,785 | $1.67M |
| 2023 | 48,392 | $2.15M |
| 2024 | 44,291 | $1.97M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 16,073 | 13,670 | $2.71M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 9,583 | 7,967 | $1.55M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5,594 | 4,658 | $957K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,851 | 1,482 | $457K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2,882 | 2,461 | $455K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 8,245 | 1,851 | $382K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,211 | 1,030 | $304K |
| 70450 | Computed tomography, head or brain; without contrast material | 2,060 | 1,725 | $300K |
| G0378 | Hospital observation service, per hour | 1,542 | 960 | $213K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,130 | 972 | $181K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,119 | 950 | $158K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,568 | 1,300 | $121K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,744 | 1,510 | $97K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,701 | 1,223 | $73K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,043 | 914 | $56K |
| 97162 | 363 | 323 | $49K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 322 | 265 | $40K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 831 | 773 | $40K |
| 71046 | Radiologic examination, chest; 2 views | 2,365 | 2,123 | $39K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 244 | 233 | $35K |
| 36415 | Collection of venous blood by venipuncture | 9,814 | 7,210 | $33K |
| 97161 | 364 | 317 | $31K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5,347 | 4,429 | $28K |
| 80053 | Comprehensive metabolic panel | 9,001 | 7,241 | $24K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 155 | 96 | $24K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 837 | 346 | $23K |
| 80048 | Basic metabolic panel (calcium, ionized) | 6,196 | 4,609 | $20K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 6,682 | 5,166 | $19K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 848 | 752 | $16K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3,725 | 2,817 | $14K |
| 71045 | Radiologic examination, chest; single view | 5,132 | 4,243 | $13K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,389 | 2,187 | $11K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 609 | 563 | $10K |
| 83880 | 1,337 | 1,072 | $10K | |
| 87400 | 685 | 594 | $9K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 69 | 54 | $9K |
| 73630 | 494 | 406 | $9K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 14,010 | 10,400 | $8K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 13 | 13 | $8K |
| 84443 | Thyroid stimulating hormone (TSH) | 1,544 | 1,316 | $7K |
| 73562 | 349 | 290 | $7K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 3,676 | 2,973 | $7K |
| 80061 | Lipid panel | 1,483 | 1,292 | $6K |
| 73610 | 201 | 181 | $6K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 495 | 436 | $5K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 463 | 418 | $5K |
| 83690 | 3,194 | 2,673 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5,311 | 2,444 | $4K |
| 84484 | 6,654 | 3,865 | $4K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 169 | 77 | $4K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 4,199 | 3,546 | $4K |
| 73130 | 178 | 146 | $3K | |
| 81001 | 6,528 | 5,438 | $3K | |
| 85379 | 1,061 | 921 | $3K | |
| 83735 | 3,651 | 2,656 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,118 | 957 | $3K |
| 80076 | 613 | 534 | $3K | |
| 96376 | 1,188 | 742 | $3K | |
| 81025 | 3,052 | 2,667 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,820 | 1,492 | $3K |
| 73030 | 244 | 203 | $3K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 4,004 | 3,122 | $3K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 124 | 73 | $2K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,201 | 1,889 | $2K |
| 87807 | 455 | 429 | $2K | |
| 82607 | 449 | 396 | $2K | |
| 82962 | 3,334 | 1,463 | $2K | |
| 87070 | 1,843 | 1,653 | $2K | |
| 80050 | General health panel | 181 | 172 | $2K |
| 85027 | 976 | 788 | $2K | |
| J2704 | Injection, propofol, 10 mg | 1,528 | 1,088 | $2K |
| 83605 | 2,385 | 1,785 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 352 | 313 | $2K |
| 97016 | 46 | 12 | $2K | |
| 87040 | 564 | 304 | $1K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 510 | 466 | $1K |
| 70486 | 14 | 12 | $1K | |
| 86756 | 52 | 48 | $1K | |
| 81003 | 2,044 | 1,757 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 175 | 149 | $1K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 13 | 12 | $1K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 352 | 313 | $1K |
| 86803 | 123 | 114 | $1K | |
| 82077 | 1,137 | 958 | $834.98 | |
| 72125 | Computed tomography, cervical spine; without contrast material | 101 | 89 | $818.47 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 3,258 | 2,651 | $782.11 |
| 84703 | 268 | 252 | $774.62 | |
| 85378 | 103 | 90 | $675.39 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 263 | 216 | $615.33 |
| 80179 | 97 | 93 | $552.60 | |
| 72100 | 19 | 17 | $503.85 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 130 | 103 | $502.66 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 522 | 442 | $446.31 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 990 | 742 | $427.64 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 96 | 86 | $367.99 |
| 99218 | 14 | 12 | $358.24 | |
| 73110 | 17 | 16 | $349.81 | |
| 80143 | 97 | 93 | $345.40 | |
| 85610 | 1,131 | 906 | $341.56 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 42 | 36 | $314.02 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 13 | 12 | $302.70 |
| 74018 | 16 | 15 | $301.74 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 681 | 554 | $288.38 |
| 97116 | 30 | 12 | $285.27 | |
| 73502 | 50 | 38 | $268.47 | |
| 82553 | 250 | 214 | $262.63 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 281 | 266 | $244.77 |
| 73560 | 35 | 25 | $234.34 | |
| 84145 | 38 | 29 | $168.60 | |
| 93356 | 177 | 148 | $150.61 | |
| J7050 | Infusion, normal saline solution, 250 cc | 571 | 412 | $120.00 |
| 36600 | 13 | 12 | $103.22 | |
| J2060 | Injection, lorazepam, 2 mg | 32 | 27 | $93.00 |
| 82570 | 72 | 52 | $84.06 | |
| 87077 | 173 | 137 | $82.11 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1,272 | 1,083 | $70.40 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 673 | 484 | $63.94 |
| 87186 | 195 | 152 | $62.86 | |
| 83540 | 27 | 25 | $55.92 | |
| 82550 | 394 | 335 | $51.13 | |
| 84466 | 13 | 12 | $33.83 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 447 | 234 | $28.19 |
| 86850 | 12 | 12 | $21.88 | |
| 86900 | 43 | 39 | $20.18 | |
| J3490 | Unclassified drugs | 1,257 | 657 | $19.82 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 156 | 126 | $18.53 |
| 82803 | 30 | 24 | $18.03 | |
| 84702 | 18 | 15 | $15.58 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 178 | 141 | $13.99 |
| 87210 | 164 | 146 | $11.90 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 425 | 365 | $11.41 |
| 86901 | 43 | 39 | $10.09 | |
| 83874 | 52 | 46 | $10.04 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 72 | 58 | $6.98 |
| J1170 | Injection, hydromorphone, up to 4 mg | 103 | 83 | $5.42 |
| 85730 | 15 | 14 | $4.21 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 108 | 85 | $3.76 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 20 | 19 | $3.53 |
| 87147 | 94 | 65 | $0.00 | |
| 74022 | 28 | 25 | $0.00 | |
| 94761 | 214 | 93 | $0.00 | |
| 94760 | 17 | 12 | $0.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 94 | 94 | $0.00 |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 12 | 12 | $0.00 |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 144 | 107 | $0.00 |
| 73140 | 13 | 13 | $0.00 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 86 | 66 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 14 | 12 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 56 | 40 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 26 | 13 | $0.00 |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | 17 | 12 | $0.00 |